These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Towards defining the role of drug eluting stents. Tarantini G; Ramondo A; Razzolini R Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166 [No Abstract] [Full Text] [Related]
4. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome]. Gil RJ Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868 [No Abstract] [Full Text] [Related]
17. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Beijk MA; Piek JJ Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467 [TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting stents: the novel application of basic science to coronary artery disease. Foley DP Ir Med J; 2002 Oct; 95(9):283. PubMed ID: 12470008 [No Abstract] [Full Text] [Related]
19. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results. Mixon T; Fitzsimmons P J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892 [No Abstract] [Full Text] [Related]
20. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]